Oncogenic action of phospholipase A2 in prostate cancer
Authors:
- Qihan DongQDQihan Dong
- Manish PatelMPManish Patel
- Kieran F. ScottKSKieran F. Scott
- Garry G. GrahamGGGarry G. Graham
- Pamela J. RussellPRPamela J. Russell
- Paul SvedPSPaul Sved
- 1 August 2006
- journal article
- review article
- Published by Elsevier in Cancer Letters
- Vol. 240 (1) , 9-16
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Celecoxib Inhibits Prostate Cancer Growth: Evidence of a Cyclooxygenase-2-Independent MechanismClinical Cancer Research, 2005
- Novel Mammalian Group XII Secreted Phospholipase A2Lacking Enzymatic Activity,Biochemistry, 2003
- Secreted phospholipase A 2 enzymes as therapeutic targetsExpert Opinion on Therapeutic Targets, 2003
- Roles for cytosolic phospholipase A2α as revealed by gene-targeted miceProstaglandins & Other Lipid Mediators, 2002
- Source of group II phospholipase A 2 in gastric juiceScandinavian Journal of Clinical and Laboratory Investigation, 2002
- A Novel Group IIA Phospholipase A2Interacts with v-Src Oncoprotein from RSV-transformed Hamster CellsJournal of Biological Chemistry, 2001
- A Distinct Sequence (ATAAA) Separates Methylated and Unmethylated Domains at the 5′-End of theGSTP1 CpG Island*Journal of Biological Chemistry, 2000
- Detailed methylation analysis of the glutathione S-transferase π (GSTP1) gene in prostate cancerOncogene, 1999
- Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteinsBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1994
- Lipocortin inhibition of extracellular and intracellular phospholipases A2 is substrate concentration dependentFEBS Letters, 1987